# Tenax Therapeutics, Inc.: filings

TENX · Nasdaq · CIK 34956 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tenx.md) · [Financials](/companies/tenx/financials.md) · [Filings](/companies/tenx/filings.md) · [Insiders](/companies/tenx/insiders.md)

## Reports and events: 321 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 183, 4 170, 10-Q 53, SCHEDULE 13G/A 49, 424B3 44, 3 30, CORRESP 28, SC 13G/A 26, SC 13G 23, DEF 14A 22, UPLOAD 21, EFFECT 20, SCHEDULE 13G 18, 10-K 17, S-3 13, PRE 14A 12, SC 13D/A 12, 8-K/A 11, D 11, S-1/A 10, S-8 10, 424B5 8, DEFA14A 8, NT 10-Q 7, ARS 4, S-1 4, SC 13D 4, 10-K/A 3, 424B4 3, 4/A 3, 5 3, POS AM 3, FWP 2, NT 10-K 2, PRER14A 2, S-3/A 2, SEC STAFF LETTER 2, 10-KT 1, 424B1 1, 8-A12B 1, CERTNAS 1, CT ORDER 1, S-1MEF 1, SCHEDULE 13D 1, SCHEDULE 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-08 | 16:15 ET | [8-K](/filings/0001193125-26-417939.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-417939 |
| 2026-09-09 | 08:00 ET | [8-K](/filings/0001193125-26-385910.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-385910 |
| 2026-08-10 | 07:19 ET | [8-K](/filings/0001193125-26-341236.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-341236 |
| 2026-07-31 | 16:15 ET | [SCHEDULE 13D/A](/filings/0001193125-26-328603.md) | Ownership report, active investor, amended | 0001193125-26-328603 |
| 2026-07-31 | 11:25 ET | [10-Q](/filings/0001193125-26-327455.md) | Quarterly report, period 2026-06-30 | 0001193125-26-327455 |
| 2026-07-31 | 07:23 ET | [8-K](/filings/0001193125-26-326784.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-326784 |
| 2026-07-02 | 08:00 ET | [8-K](/filings/0001193125-26-293485.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-293485 |
| 2026-06-30 | 16:30 ET | [8-K](/filings/0001193125-26-290661.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-290661 |
| 2026-06-29 | 16:40 ET | [8-K](/filings/0001193125-26-288600.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-288600 |
| 2026-06-04 | 16:10 ET | [8-K](/filings/0001193125-26-257400.md) | 5.07 Shareholder vote results | 0001193125-26-257400 |
| 2026-05-12 | 16:06 ET | [10-Q](/filings/0001193125-26-219383.md) | Quarterly report, period 2026-03-31 | 0001193125-26-219383 |
| 2026-05-12 | 08:00 ET | [8-K](/filings/0001193125-26-218224.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-218224 |
| 2026-04-22 | 08:17 ET | [DEF 14A](/filings/0001193125-26-168580.md) | Proxy statement, period 2026-04-17 | 0001193125-26-168580 |
| 2026-04-22 | 08:00 ET | [8-K](/filings/0001193125-26-168521.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-168521 |
| 2026-03-10 | 18:02 ET | [SCHEDULE 13D](/filings/0001654954-26-002112.md) | Ownership report, active investor | 0001654954-26-002112 |
| 2026-03-10 | 07:48 ET | [10-K](/filings/0001193125-26-099393.md) | Annual report, period 2025-12-31 | 0001193125-26-099393 |
| 2026-03-10 | 07:32 ET | [8-K](/filings/0001654954-26-002072.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-26-002072 |
| 2026-01-09 | 16:33 ET | [8-K](/filings/0001654954-26-000232.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001654954-26-000232 |
| 2025-12-17 | 17:00 ET | [8-K](/filings/0001654954-25-014059.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-25-014059 |
| 2025-11-12 | 16:40 ET | [10-Q](/filings/0001193125-25-277793.md) | Quarterly report, period 2025-09-30 | 0001193125-25-277793 |
| 2025-11-12 | 16:38 ET | [8-K](/filings/0001654954-25-012921.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-25-012921 |
| 2025-09-16 | 08:10 ET | [8-K](/filings/0001654954-25-010792.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-25-010792 |
| 2025-09-09 | 08:02 ET | [8-K](/filings/0001654954-25-010510.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001654954-25-010510 |
| 2025-08-13 | 16:22 ET | [10-Q](/filings/0000950170-25-108063.md) | Quarterly report, period 2025-06-30 | 0000950170-25-108063 |
| 2025-08-13 | 16:21 ET | [8-K](/filings/0001654954-25-009510.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-25-009510 |
| 2025-06-17 | 16:30 ET | [8-K](/filings/0001654954-25-007104.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001654954-25-007104 |
| 2025-05-14 | 16:12 ET | [10-Q](/filings/0000950170-25-071395.md) | Quarterly report, period 2025-03-31 | 0000950170-25-071395 |
| 2025-05-14 | 16:09 ET | [8-K](/filings/0000950170-25-071382.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-071382 |
| 2025-04-25 | 07:42 ET | [DEF 14A](/filings/0000950170-25-058329.md) | Proxy statement, period 2025-04-24 | 0000950170-25-058329 |
| 2025-03-25 | 16:15 ET | [10-K](/filings/0000950170-25-044398.md) | Annual report, period 2024-12-31 | 0000950170-25-044398 |
| 2025-03-25 | 16:10 ET | [8-K](/filings/0000950170-25-044375.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-044375 |
| 2025-03-06 | 17:00 ET | [8-K](/filings/0001654954-25-002385.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-25-002385 |
| 2024-12-04 | 17:16 ET | [8-K](/filings/0001654954-24-015161.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001654954-24-015161 |
| 2024-11-13 | 16:04 ET | [10-Q](/filings/0001654954-24-014262.md) | Quarterly report, period 2024-09-30 | 0001654954-24-014262 |
| 2024-11-13 | 08:15 ET | [8-K](/filings/0001654954-24-014203.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-24-014203 |
| 2024-10-30 | 16:32 ET | [8-K](/filings/0001654954-24-013505.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001654954-24-013505 |
| 2024-09-27 | 08:14 ET | [DEF 14A](/filings/0001654954-24-012375.md) | Proxy statement, period 2024-10-25 | 0001654954-24-012375 |
| 2024-08-13 | 16:45 ET | [10-Q](/filings/0001654954-24-010456.md) | Quarterly report, period 2024-06-30 | 0001654954-24-010456 |
| 2024-08-13 | 16:30 ET | [8-K](/filings/0001654954-24-010454.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-24-010454 |
| 2024-08-12 | 08:35 ET | [8-K](/filings/0001654954-24-010278.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-24-010278 |
| 2024-08-06 | 07:23 ET | [8-K](/filings/0001654954-24-009988.md) | 9.01 Financial statements and exhibits | 0001654954-24-009988 |
| 2024-06-13 | 16:32 ET | [8-K](/filings/0001654954-24-007727.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001654954-24-007727 |
| 2024-05-14 | 16:01 ET | [10-Q](/filings/0001654954-24-006228.md) | Quarterly report, period 2024-03-31 | 0001654954-24-006228 |
| 2024-05-14 | 09:01 ET | [8-K](/filings/0001654954-24-006131.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-24-006131 |
| 2024-04-26 | 08:30 ET | [DEF 14A](/filings/0001654954-24-005065.md) | Proxy statement, period 2024-06-07 | 0001654954-24-005065 |
| 2024-03-28 | 14:02 ET | [10-K](/filings/0001654954-24-003827.md) | Annual report, period 2023-12-31 | 0001654954-24-003827 |
| 2024-03-28 | 08:45 ET | [8-K](/filings/0001654954-24-003775.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-24-003775 |
| 2024-02-23 | 16:30 ET | [8-K](/filings/0001654954-24-002134.md) | 8.01 Other events | 0001654954-24-002134 |
| 2024-02-20 | 08:33 ET | [8-K](/filings/0001654954-24-001923.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001654954-24-001923 |
| 2024-02-12 | 16:46 ET | [8-K](/filings/0001654954-24-001591.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-24-001591 |

Page 1 of 7. [Older](/companies/tenx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:29 ET. No prices; not investment advice.